Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Acta Neuropathologica|February 22, 2019
Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigmsMaria Masnata, Giacomo Sciacca, Alexander Maxan, et al.Neurobiology of Disease|October 10, 2024
Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse modelsShireen Salem, Melanie Alpaugh, Martine Saint-Pierre, et al.Annals of Neurology|November 25, 2017
Mutant huntingtin protein expression and blood-spinal cord barrier dysfunction in huntington diseaseGiacomo Sciacca, Francesca CicchettiJournal of Huntington'S Disease|February 22, 2023
Untangling the Role of Tau in Huntington's Disease PathologyShireen Salem, Francesca CicchettiJournal of Experimental Neuroscience|May 16, 2018
Tau: A Common Denominator and Therapeutic Target for Neurodegenerative DisordersAlexander Maxan, Francesca CicchettiFrontiers in Neuroscience|December 14, 2017
The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in <i>in Vitro</i> Systems and Their Therapeutic ImplicationsMaria Masnata, Francesca CicchettiMolecular Psychiatry|September 25, 2023
Tau: a biomarker of Huntington's diseaseEva Lepinay, Francesca CicchettiNeurobiology of Disease|June 26, 2026
Mutant huntingtin in the extracellular matrix: A new perspective on Huntington disease pathologyChristine Trabolsi, Francesca CicchettiNeurobiology of Disease|May 23, 2020
Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primatesAlexander Maxan, Giacomo Sciacca, Melanie Alpaugh, et al.Biology|October 25, 2024
Investigating the Interplay between Cardiovascular and Neurodegenerative DiseaseJason Patrick Cousineau, Aimee Maria Dawe, Melanie AlpaughPageof 10